August 6, 2019 Clinical Research/Diagn. Lab Top-10 Product Launch

New Instrument for Automated Antimicrobial Susceptibility Testing Provides Gold Standard-Level Minimum Inhibitory Concentration (MIC) Accuracy[1]

New Instrument for Automated Antimicrobial Susceptibility Testing Provides Gold Standard-Level Minimum Inhibitory Concentration (MIC) Accuracy[1] Instrument utilizes gold standard broth microdilution method to guide more targeted patient therapy and optimize patient outcomes ANAHEIM, Calif., Aug. 6, 2019 /PRNewswire/ — AACC 2019 – A new benchtop automated reading and incubation system for antimicrobial susceptibility testing (AST) provides microbiology... Read more

August 5, 2019 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 Product Launch

New Expanded Analytical Instrument Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories

New Expanded Analytical Instrument Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories Thermo Scientific Medical Device portfolio provides an extensive range of chromatography and mass spectrometry instruments for performing laboratory developed tests ANAHEIM, Calif. – AACC 2019 – (August 6, 2019) – Thermo Fisher Scientific has expanded its portfolio of analytical... Read more

August 5, 2019 Clinical Research/Diagn. Lab Top-10 Product Launch

New Blood Tests Help Assess Asthma Risk and Decide Pet Selection

ImmunoCAP Allergen Components test for specific proteins that cause allergic sensitization to dogs, cats and horses ANAHEIM, Calif.  – AACC 2019 – (August 6, 2019)—New blood tests may help healthcare providers identify if patients are sensitized to up to 11 different molecular allergen component proteins found in dogs, cats, or horses. The assays analyze sensitivity... Read more

August 5, 2019 Clinical Research/Diagn. Lab Top-10 PR/Corporate Product Launch

Thermo Fisher Scientific Showcases New Innovations for the Clinic During AACC 2019

Thermo Fisher Scientific Showcases New Innovations for the Clinic During AACC 2019 ANAHEIM, Calif. – AACC 2019 – (August 6, 2019) – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is showcasing its latest instruments, assays and software for improving speed, accuracy and usability across clinical and research labs during the... Read more

August 5, 2019 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Enzo Biochem, Inc. Announces Issuance of United States Patent for Advanced Nucleic Acid Hybridization Probe Technology for Clinical and Research Applications

Transformative Development in Diagnostic Testing, Drug Development and Academic Research Marketplace Provides a Simple, Cost Effective and Scalable Process — — New Probe Technology Advances Company’s Ability to Offer Lower-Cost High-Performance Products and Services in the Clinical Diagnostics Market NEW YORK, NY, August 5, 2019 — Enzo Biochem, Inc. (NYSE: ENZ), an integrated diagnostics and... Read more

July 31, 2019 Acad, Gov/Utilities Atomic Spectroscopy Bio/Pharma/CRO Chromatography Clinical Research/Diagn. Lab Top-10

Agilent Companion Diagnostic Gains Expanded FDA Approval in Esophageal Squamous Cell Carcinoma (ESCC)

Agilent Companion Diagnostic Gains Expanded FDA Approval in Esophageal Squamous Cell Carcinoma (ESCC) PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify ESCC patients SANTA CLARA, Calif., July 31, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s PD-L1 IHC... Read more

July 31, 2019 Atomic Spectroscopy Clinical Research/Diagn.

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

Basel, 31 July 2019 Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has extended the offering period of its previously announced tender offer to purchase all of the outstanding shares... Read more

July 30, 2019 Cell Analysis Tools Clinical Research/Diagn. M&A, Partnerships

NanoString Technologies and Mayo Clinic Laboratories Enter Joint Development Agreement to Develop Novel Assays

SEATTLE and ROCHESTER, Minn., July 30, 2019 (GLOBE NEWSWIRE) — NanoString Technologies and Mayo Clinic Laboratories have announced a collaboration to develop clinical tests using NanoString’snew GeoMx Digital Spatial Profiler. GeoMx combines spatial and molecular profiling technologies by generating a whole tissue image at single cell resolution while also providing digital profiling data for tens to thousands of RNA or protein analytes for up... Read more

July 25, 2019 Clinical Research/Diagn. Informatics & Software Product Launch

Cytel launches East On Demand bringing adaptive clinical trial design capabilities to wider biopharma audience

Cambridge, MA, July 25, 2019 – Cytel Inc., the leading global provider of analytical solutions to the life sciences industry, today announced that it will launch East On Demand™ at the annual Joint Statistical Meetings (JSM) 2019 (July 27 – August 1, Denver, Colorado). Offered via the cloud and licensed through subscriptions, East On Demand provides statisticians with... Read more